Recent Updates
Recently added Catalysts
ACB Positive Sentiment Score: 70/100

Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2024 Investor Conference Call and File Related Year End Information NASDAQ | TSX

Key Takeaway: Aurora Cannabis Inc. has announced an investor conference call to discuss its fourth quarter and fiscal year 2024 results, scheduled for June 20, 2024. The company will release its financial results before the market opens that day. This call will be hosted by CEO Miguel Martin and CFO Simona King. As part of its communication strategy, Aurora aims to keep investors informed about its financial performance and future prospects.

Market Sentiment Analysis

POSITIVE FACTORS

  • Aurora Cannabis is poised to report its financial results, which indicates ongoing transparency.
  • The scheduled investor conference call reflects Aurora's commitment to engaging with stakeholders.
  • Aurora continues to expand its product offerings across multiple markets, showcasing its leadership in the cannabis industry.

Full Press Release Details

Aurora Cannabis to Host Fourth Quarter and Fiscal
Year 2024 Investor Conference Call and File Related Year End Information
EDMONTON, AB, June 7, 2024 /CNW/ - Aurora Cannabis
Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company,
announced today that it has scheduled a conference call to discuss the results for its fourth quarter and fiscal year 2024 on Thursday,
June 20, 2024 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the fourth quarter
fiscal year 2024 before the opening of markets that same day.
Conference Call Details
DATE: Thursday, June 20, 2024
TIME: 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time
WEBCAST: Click Here
Miguel Martin, Chief Executive Officer, and Simona
King, Chief Financial Officer, will host the conference call and question and answer period. This weblink has also been posted to the
Company's "Investor Info" link at https://www.auroramj.com/investors/ under "Events".
About Aurora Cannabis
Aurora is opening the world to cannabis, serving both
the medical and consumer markets across Canada, Europe, Australia and South America. Headquartered in Edmonton, Alberta, Aurora is a pioneer
in global cannabis, dedicated to helping people improve their lives. The Company's adult-use brand portfolio includes Drift, San Rafael
'71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana
Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd.,
North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality
cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets
Aurora's common shares trade on the NASDAQ and TSX
under the symbol "ACB".
For Media: For Investors:
Michelle Lefler ICR, Inc.
VP, Communications & PR Investor Relations
media@auroramj.com aurora@icrinc.com
Forward Looking Statements
This news release includes statements containing certain
"forward looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan", "continue", "expect", "project",
"intend", "believe", "anticipate", "estimate", "may", "will", "potential",
"proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur.
Forward-looking statements made in this news release include statements regarding timing of the release of the Company's financial statements
for fourth quarter and fiscal year ended March 31, 2024 and scheduling of the conference call to discuss results.
These forward-looking statements are only predictions.
Forward looking information or statements contained in this news release have been developed based on assumptions management considers
to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly
available information from governmental sources as well as from market research and industry analysis and on assumptions based on data
and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks,
uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events,
results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking
statements. These risks include, but are not limited to, the ability to retain key personnel, the ability to continue investing in infrastructure
to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and
retention, the development of third party government and nongovernment consumer sales channels, management's estimates of consumer demand
in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration
of acquired business and operations, management's estimation that SG&A will grow only in proportion of revenue growth, the ability
to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield
from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes
in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises, and other risks, uncertainties and
factors set out under the heading "Risk Factors" in the Company's annual information form dated June 14, 2023 (the "AIF")
and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR at www.sedarplus.com and filed with and
available on the SEC's website at www.sec.gov. The Company cautions that the list of risks, uncertainties and other factors described
in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties
and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information.
The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.
SOURCE Aurora Cannabis Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2024/07/c9710.html
CO: Aurora Cannabis Inc.
CNW 07:00e 07-JUN-24

Frequently Asked Questions

When is Aurora Cannabis' fiscal year 2024 conference call?

The conference call is scheduled for Thursday, June 20, 2024, at 8:00 a.m. ET.

Who will host the investor conference call?

Miguel Martin, CEO, and Simona King, CFO, will host the call.

What information will Aurora report on June 20, 2024?

Aurora will report its financial results for the fourth quarter of fiscal year 2024.

Where can I access the conference call webcast?

The webcast is available on Aurora's Investor Info page on their website.

What is Aurora Cannabis known for?

Aurora is a leading cannabis company, operating in medical and consumer markets globally.

Last updated: Jun 7, 2024